| Autor: |
Cupido GF; ENT Department, University of Palermo, Palermo, Italy, Gelardi M; Otolaryngology Unit, Department of Basic Medical Science, Neuroscience and Sensory Organs, University of Bari Aldo Moro, Bari, Italy, La Mantia I; ENT Department, University of Catania, Catania, Italy, Aragona SE; Center of Regenerative Medicine, Humanitas Mater Domini, Castellanza (VA), Italy, Ciprandi G; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy |
| Abstrakt: |
Inflammation is a common pathogenic mechanism involved in many otorhinolaryngological (ORL) disorders. Broser® is an oral nutraceutical currently containing bromelain 100 mg, escin 30 mg, and selenium 42.5 mcg. It could exert a safe and effective anti-inflammatory activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients. |
